Bioburden Testing Market to Value Over USD 1.3 Billion By 2026

  • 21 Aug 2019

Global Bioburden Testing Market is anticipated to witness value over USD 1.3 billion during the forecast period 2019 to 2026 with a CAGR of over 11%.

Bioburden tests are microbial limit tests that are used for the detection of contamination in products. The rising growth of pharmaceutical products, medical devices, food and beverage industries, etc. are the driving factors for the bioburden testing market growth.

Based on the product, the culture media and reagents are expected to be the dominating segment in the market. Culture media and reagents are vital parts of bioburden testing. The culture media selection differs depending on the type of testing method to be used. The variety and selectivity of culture media is the key factor for the increase in the bioburden testing market share.

The anaerobic type of testing method is estimated to have more demand in the market. The method is used in raw material testing in pharma companies. Since contamination in raw materials is not acceptable for further procedures, the preference for anaerobic testing is high. Raw materials are a vital part of the production process. Hence, expenditure spent on raw material testing is more and contribute to a major bioburden testing market share.

The medical device manufacturers, and pharmaceutical and biotechnology industries tend to hold a large market share compared to other end users. Contamination of medical devices is the primary reason for obtaining wrong results along with huge economic losses, so conducting appropriate bioburden tests of medical devices is a necessity which increases its market demand. Pharmaceutical companies have to perform bioburden testing at each step of production and on each type of ingredient and equipment. Expenditure assigned to bioburden testing by pharma companies is significantly contributing to bioburden testing market growth.

The massive consumption of dairy products and protein-rich meat is the key element responsible for dominating the market in North America. The investment in the bioburden testing organizations and research centres is the key factor. The Asia Pacific is estimated to hold a large share in the bioburden testing market. The rising population and demand for dairy and meat products are high in this region contributing to bioburden testing market growth.

The major companies are Charles River, Merck KGaA, SGS SA, Wuxi Apptec and so on. Merck KGaA is one of the major key players in the bioburden testing market. It has a range of testing facilities for food and beverages, pharmaceuticals, clinical and diagnostics, and so on.

FutureWise Key Takeaways:

●    New advancements in bioburden testing methods

●    Investment in bioburden consumables products

●    Collaboration bioburden testing organizations

Global Bioburden Testing Market Segmentation:

By Product

●    Consumables

●    Instruments

By Test Type

●    Aerobic count testing

●    Anaerobic count testing

●    Fungi/ Mold count testing

●    Spore count testing

By Application

●    Raw material testing

●    Medical device testing

●    In-process material testing

●    Sterilization validation testing

●    Equipment cleaning validation

By End User

●    Pharmaceutical and biotechnology companies

●    Medical device manufacturers

●    Contract manufacturing organizations

●    Manufacturers of Food & Beverage and Agricultural Products

●    Microbial Testing Laboratories

By Region

●    North America

●    Europe

●    Asia Pacific

●    Rest of the world

Competitive Landscape:

●    Tier 1 players- established companies in the market with a major market share

●    Tier 2 players

●    Emerging players which are growing rapidly

●    New Entrants

Objectives of the Study:

●    To provide with an exhaustive analysis on the bioburden testing market by product, by test type, by application, by end user and by region

●    To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

●    To evaluate and forecast micro-markets and the overall market

●    To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, and the rest of the world

●    To record evaluate and competitive landscape mapping-product launches, technological advancements, mergers and expansions

●    Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com